Non-invasive Prediction of Molecular and Histopathological Subtypes in Murine and Human Pancreatic Ductal Adenocarcinoma Using [18F]FDG PET

Purpose This study evaluates the utility of [ 18 F]fluorodeoxyglucose positron emission tomography ([ 18 F]FDG PET) for Pancreatic ductal adenocarcinoma (PDAC) subtype differentiation across preclinical and clinical settings, and assesses the impact of tracer uptake timing on subtype discrimination. Methods [ 18 F]FDG uptake was investigated in classical (C)-HPAC and quasi-mesenchymal (QM)-PSN1 cells, heterotopic rat (n = 11), orthotopic mouse xenografts (n = 8), and gland-forming (GF)/non-GF tumors from seven genetically engineered mouse models (GEMMs). Retrospective [ 18 F]FDG PET data from 16 PDAC patients were analyzed using subtype classification based on keratin-81 (KRT81+(QM)/KRT81-(non-QM)). Dynamic and static [ 18 F]FDG PET parameters, including standard uptake value (SUV) mean , SUV max , and mean tumor-to-muscle ratio (T/M mean ), were evaluated for subtype discrimination. Results QM tumors showed significantly higher [ 18 F]FDG uptake than C tumors in vitro (50.7 ± 1.03% vs. 19.4 ± 2.37%), in heterotopic (SUV max 6.91 ± 1.14 vs. 2.66 ± 0.28), and orthotopic (SUV max 2.85 ± 0.70 vs. 1.45 ± 0.50) xenografts. Non-GF tumors also showed significantly higher uptake than GF (SUV max 3.94 ± 0.70 vs. 2.53 ± 0.97). Patients showed a similar trend (SUV max 6.33 ± 1.74 vs. 4.95 ± 1.46), with shorter overall survival in QM tumors. Dynamic PET revealed continued tracer accumulation in QM/non-GF tumors throughout the 90-minute acquisition period, whereas C/GF tumors approached a plateau by approximately 60 minutes. T/M mean showed the best classification performance across all models. Conclusion [ 18 F]FDG PET differentiated PDAC subtypes across all preclinical models with a similar but less pronounced trend in patients. Later imaging time points showed enhanced metabolic separation, suggesting potential benefits for improving non-invasive subtype discrimination. Clinical Trial Registration N/A

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11729028/v1
Primary Topic
Medical Imaging Techniques and Applications
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Non-invasive Prediction of Molecular and Histopathological Subtypes in Murine and Human Pancreatic Ductal Adenocarcinoma Using [18F]FDG PET

Irina Heid, Romina Karampour
Research Square
Medical Imaging Techniques and Applications
preprint

Non-invasive Prediction of Molecular and Histopathological Subtypes in Murine and Human Pancreatic Ductal Adenocarcinoma Using [18F]FDG PET

Irina Heid, Romina Karampour
preprint en

Abstract

Purpose This study evaluates the utility of [ 18 F]fluorodeoxyglucose positron emission tomography ([ 18 F]FDG PET) for Pancreatic ductal adenocarcinoma (PDAC) subtype differentiation across preclinical and clinical settings, and assesses the impact of tracer uptake timing on subtype discrimination. Methods [ 18 F]FDG uptake was investigated in classical (C)-HPAC and quasi-mesenchymal (QM)-PSN1 cells, heterotopic rat (n = 11), orthotopic mouse xenografts (n = 8), and gland-forming (GF)/non-GF tumors from seven genetically engineered mouse models (GEMMs). Retrospective [ 18 F]FDG PET data from 16 PDAC patients were analyzed using subtype classification based on keratin-81 (KRT81+(QM)/KRT81-(non-QM)). Dynamic and static [ 18 F]FDG PET parameters, including standard uptake value (SUV) mean , SUV max , and mean tumor-to-muscle ratio (T/M mean ), were evaluated for subtype discrimination. Results QM tumors showed significantly higher [ 18 F]FDG uptake than C tumors in vitro (50.7 ± 1.03% vs. 19.4 ± 2.37%), in heterotopic (SUV max 6.91 ± 1.14 vs. 2.66 ± 0.28), and orthotopic (SUV max 2.85 ± 0.70 vs. 1.45 ± 0.50) xenografts. Non-GF tumors also showed significantly higher uptake than GF (SUV max 3.94 ± 0.70 vs. 2.53 ± 0.97). Patients showed a similar trend (SUV max 6.33 ± 1.74 vs. 4.95 ± 1.46), with shorter overall survival in QM tumors. Dynamic PET revealed continued tracer accumulation in QM/non-GF tumors throughout the 90-minute acquisition period, whereas C/GF tumors approached a plateau by approximately 60 minutes. T/M mean showed the best classification performance across all models. Conclusion [ 18 F]FDG PET differentiated PDAC subtypes across all preclinical models with a similar but less pronounced trend in patients. Later imaging time points showed enhanced metabolic separation, suggesting potential benefits for improving non-invasive subtype discrimination. Clinical Trial Registration N/A

Research Square
TUM Klinikum (DE), Technical University of Munich (DE)
Medical Imaging Techniques and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon